Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates in the US and Europe. It is headquartered in Salt Lake City, Utah.

Scope

– Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs.

– A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis.

– An in-depth view of the busines

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.

-

Companies mentioned

Myriad Genetics, Inc.

Table of Contents

Table of Contents

Company Snapshot

Myriad Genetics, Inc.: Company Overview

Myriad Genetics, Inc.: Overview and Key Facts

Myriad Genetics, Inc.: Overview

Myriad Genetics, Inc.: Key Facts

Myriad Genetics, Inc.: Key Employees

Myriad Genetics, Inc.: Key Employee Biographies

Myriad Genetics, Inc.: Major Products and Services

Myriad Genetics, Inc.: Company History

Myriad Genetics, Inc.: Management Statement

Myriad Genetics, Inc.: Locations and Subsidiaries

Myriad Genetics, Inc.: Key Competitors

Myriad Genetics, Inc.: Company Analysis

Myriad Genetics, Inc.: Business Description

Myriad Genetics, Inc.: SWOT Analysis

Myriad Genetics, Inc.: SWOT Overview

Myriad Genetics, Inc.: Strengths

Myriad Genetics, Inc.: Weaknesses

Myriad Genetics, Inc.: Opportunities

Myriad Genetics, Inc.: Threats

Myriad Genetics, Inc.: Corporate Financial Deals Activity

Myriad Genetics, Inc.: Financial Deals Overview

Myriad Genetics, Inc.: Targets and Partners

Myriad Genetics, Inc.: Top Deals 2013 - 2017YTD*

Myriad Genetics, Inc.: Mergers and Acquisitions

Myriad Genetics, Inc.: Corporate Venturing

Myriad Genetics, Inc.: Partnership

Myriad Genetics, Inc.: Recent Developments

Myriad Genetics, Inc.: News and Events Summary

Myriad Genetics, Inc.: Contracts

Myriad Genetics, Inc.: Corporate Governance

Myriad Genetics, Inc.: Financial Performance

Myriad Genetics, Inc.: Research & Development

Myriad Genetics, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About MarketLine

List of Tables

List of Tables

Table 1: Myriad Genetics, Inc.: Key Facts

Table 2: Myriad Genetics, Inc.: Key Employees

Table 3: Myriad Genetics, Inc.: Locations and Subsidiaries

Table 4: Myriad Genetics, Inc.: Key Competitors

Table 5: Myriad Genetics, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Table 7: Myriad Genetics, Inc.: M&A Average Deal Size – Value (US$m)

Table 8: Myriad Genetics, Inc.: Targets and Partners

Table 9: Myriad Genetics, Inc.: Top Deals 2013 – 2017YTD*

Table 10: Myriad Genetics, Inc.: M&A Volume and Value Trend (2013 – YTD*2017)

Table 11: Myriad Genetics, Inc.: M&A Activity by Geography (2013 – YTD*2017)

Table 12: Myriad Genetics, Inc.: Corporate Venturing Volume and Value Trend (2013 – YTD*2017)

Table 13: Myriad Genetics, Inc.: Corporate Venturing by Geography (2013 – YTD*2017)

Table 14: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2013 – YTD*2017)

Table 15: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2013 – YTD*2017)

Table 16: Myriad Genetics, Inc.: News and Events Summary

Table 17: Myriad Genetics, Inc.: Contracts

Table 18: Myriad Genetics, Inc.: Corporate Governance

Table 19: Myriad Genetics, Inc.: Financial Performance

Table 20: Myriad Genetics, Inc.: Research & Development

Table 21: Myriad Genetics, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Myriad Genetics, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Myriad Genetics, Inc.: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Figure 3: Myriad Genetics, Inc.: M&A Average Deal Size – Value (US$m)

Figure 4: Myriad Genetics, Inc.: M&A Volume and Value Trend (2013 – YTD*2017)

Figure 5: Myriad Genetics, Inc.: M&A Activity by Geography (2013 – YTD*2017)

Figure 6: Myriad Genetics, Inc.: Corporate Venturing Volume and Value Trend (2013 – YTD*2017)

Figure 7: Myriad Genetics, Inc.: Corporate Venturing by Geography (2013 – YTD*2017)

Figure 8: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2013 – YTD*2017)

Figure 9: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2013 – YTD*2017)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports